Active Not RecruitingNCT05474846
CBT with light therapy, melatonin and/or methylphenidate for sleep problems in advanced cancer
About this title
Read the official source — NCT05474846Medication studyAges 18+United StatesAnxiety
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- HoustonSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 21, 2022
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 169
- Sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05474846
- Official title
Show the full official title
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Houston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is M.D. Anderson Cancer Center.
Does this study involve medication?
Yes. The study involves medication, including Melatonin and Methylphenidate.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
